Literature DB >> 33598893

Insights into the Regulation on Proliferation and Differentiation of Stem Leydig Cells.

Zhuo-Jie Liu1, Yong-Hui Liu1, Sheng-Yu Huang1, Zhi-Jun Zang2.   

Abstract

Male hypogonadism is a clinical syndrome caused by testosterone deficiency. Hypogonadism can be caused by testicular disease (primary hypogonadism) or hypothalamic-pituitary dysfunction (secondary hypogonadism). The present strategy for treating hypogonadism is the administration of exogenous testosterone. But exogenous testosterone is reported to have negative side effects including adverse cardiovascular events and disruption of physiological spermatogenesis probably due to its inability to mimic the physiological circadian rhythm of testosterone secretion in vivo. In recent years, a growing number of articles demonstrated that stem Leydig cells (SLCs) can not only differentiate into functional Leydig cells (LCs) in vivo to replace chemically disrupted LCs, but also secrete testosterone in a physiological pattern. The proliferation and differentiation of SLCs are regulated by various factors. However, the mechanisms involved in regulating the development of SLCs remain to be summarized. Factors involved in the regulation of SLCs can be divided into environmental pollutants, growth factors, cytokine and hormones. Environmental pollutants such as Perfluorooctanoic acid (PFOA) and Triphenyltin (TPT) could suppress SLCs proliferation or differentiation. Growth factors including FGF1, FGF16, NGF and activin A are essential for the maintenance of SLCs self-renewal and differentiation. Interleukin 6 family could inhibit differentiation of SLCs. Among hormones, dexamethasone suppresses SLCs differentiation, while aldosterone suppresses their proliferation. The present review focuses on new progress about factors regulating SLC's proliferation and differentiation which will undoubtedly deepen our insights into SLCs and help make better clinical use of them. Different factors affect on the proliferation and differentiation of stem Leydig cells. Firstly, each rat was intraperitoneally injected EDS so as to deplete Leydig cells from the adult testis. Secondly, the CD51+ or CD90+ cells from the testis of rats are SLCs, and the p75+ cells from human adult testes are human SLCs. These SLCs in the testis start to proliferate and some of them differentiate into LCs. Thirdly, during the SLCs regeneration period, researchers could explore different function of those factors (pollutants, growth factors, cytokines and hormones) towards SLCs.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  (pollutants; Cytokines and hormones) regulation; Differentiation; Male hypogonadism; Proliferation; Stem Leydig cells; Testosterone supplement

Mesh:

Substances:

Year:  2021        PMID: 33598893     DOI: 10.1007/s12015-021-10133-x

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  68 in total

1.  Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

Authors:  Michael J Diver; Komal E Imtiaz; Aftab M Ahmad; Jiten P Vora; William D Fraser
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

Review 2.  Age-related changes in testosterone and the role of replacement therapy in older men.

Authors:  Carolyn A Allan; Robert I McLachlan
Journal:  Clin Endocrinol (Oxf)       Date:  2004-06       Impact factor: 3.478

3.  Investigation, treatment and monitoring of late-onset hypogonadism in males.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Aging Male       Date:  2005-06       Impact factor: 5.892

Review 4.  Novel Therapy for Male Hypogonadism.

Authors:  Robert Carrasquillo; Kevin Chu; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2018-06-09       Impact factor: 3.092

Review 5.  Cell interactions and genetic regulation that contribute to testicular Leydig cell development and differentiation.

Authors:  Luc J Martin
Journal:  Mol Reprod Dev       Date:  2016-04-26       Impact factor: 2.609

6.  Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency.

Authors:  Zhi Jun Zang; Jiancheng Wang; Zhihong Chen; Yan Zhang; Yong Gao; Zhijian Su; Ying Tuo; Yan Liao; Min Zhang; Qunfang Yuan; Chunhua Deng; Mei Hua Jiang; Andy Peng Xiang
Journal:  Stem Cells       Date:  2017-03-05       Impact factor: 6.277

Review 7.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

Review 8.  Testosterone replacement therapy for late-onset hypogonadism.

Authors:  Glenn R Cunningham
Journal:  Nat Clin Pract Urol       Date:  2006-05

9.  Low testosterone and the risk of dementia in elderly men: Impact of age and education.

Authors:  Laure Carcaillon; Sylvie Brailly-Tabard; Marie-Laure Ancelin; Christophe Tzourio; Alexandra Foubert-Samier; Jean-François Dartigues; Anne Guiochon-Mantel; Pierre-Yves Scarabin
Journal:  Alzheimers Dement       Date:  2013-09-10       Impact factor: 21.566

Review 10.  Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism.

Authors:  Taylor C Peak; Nora M Haney; William Wang; Kenneth J DeLay; Wayne J Hellstrom
Journal:  World J Stem Cells       Date:  2016-10-26       Impact factor: 5.326

View more
  2 in total

1.  Expression of Nerve Growth Factor and Its Receptor TrkA in the Reproductive System of Adult Zebrafish.

Authors:  Pietro Cacialli
Journal:  Vet Sci       Date:  2022-05-06

2.  Comparative Cytotoxic Effects and Possible Mechanisms of Deoxynivalenol, Zearalenone and T-2 Toxin Exposure to Porcine Leydig Cells In Vitro.

Authors:  Lingwei Sun; Jianjun Dai; Jiehuan Xu; Junhua Yang; Defu Zhang
Journal:  Toxins (Basel)       Date:  2022-02-02       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.